Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluorocarbon emulsions

A Marchbank1

  • 1Department of Cardiothoracic Surgery, National Heart and Lung Institute, London, UK.

Perfusion
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Second-generation perfluorocarbon emulsions require individual efficacy and toxicity assessments. Despite ongoing research, their clinical use as blood substitutes remains uncertain.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anaesthetic and surgical management of rib fractures.

BJA education·2021
Same author

Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients - control survival is much better than previously assumed.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2020
Same author

Effectiveness of a gentamicin impregnated collagen sponge on reducing sternal wound infections following cardiac surgery: a meta-analysis of randomised controlled trials.

Annals of the Royal College of Surgeons of England·2012
Same author

Diagnostic and therapeutic performance of video-assisted thoracoscopic surgery (VATS) in investigation and management of pleural exudates.

Annals of the Royal College of Surgeons of England·2008
Same author

Impact of preoperative screening for meticillin-resistant Staphylococcus aureus by real-time polymerase chain reaction in patients undergoing cardiac surgery.

The Journal of hospital infection·2008
Same author

Implementation of the British Thoracic Society recommendations for organising the care of patients with lung cancer: the surgeon's perspective.

Annals of the Royal College of Surgeons of England·2002
Same journal

Efficacy of intraoperative hemoadsorption in patients undergoing cardiac surgery, a meta-analysis.

Perfusion·2026
Same journal

Trileaflet mitral valve in hypertrophic obstructive cardiomyopathy: A rare anatomical variant requiring surgical intervention.

Perfusion·2026
Same journal

Corrigendum to: "A comparison of continuous blood gas monitors during cardiopulmonary bypass LivaNova B-capta, terumo CDI 500, spectrum medical M4".

Perfusion·2026
Same journal

ROTEM versus conventional coagulation tests in evaluating coagulopathy and transfusion requirement in ECMO patients: A retrospective study.

Perfusion·2026
Same journal

Safety and efficacy of transcatheter aortic valve replacement (TAVR) vs. surgical aortic valve replacement (SAVR) in patients with bicuspid aortic stenosis: A Systematic review and meta-analysis.

Perfusion·2026
Same journal

External validation of the population pharmacokinetic model of meropenem in patients undergoing neonatal extracorporeal membrane oxygenation and continuous renal replacement therapy.

Perfusion·2026
See all related articles

Area of Science:

  • Biomedical Engineering
  • Drug Development
  • Clinical Pharmacology

Background:

  • Perfluorocarbon emulsions have been investigated for decades.
  • Early clinical studies yielded disappointing results due to underdeveloped formulations.
  • A negative perception persists, necessitating re-evaluation of newer emulsions.

Purpose of the Study:

  • To assess the efficacy and toxicity of second-generation perfluorocarbon emulsions.
  • To highlight the need for individualized evaluation of new formulations.
  • To explore the future potential and limitations of perfluorocarbon emulsions.

Main Methods:

  • Review of existing clinical studies and technological advancements.
  • Emphasis on laboratory testing of new formulations.

Related Experiment Videos

  • Analysis of perfluorocarbon emulsion properties and mechanisms.

    • Main Results:

    • No absolute clinical indications currently exist for perfluorocarbon emulsions.
    • Newer emulsions require rigorous, case-by-case evaluation.
    • Technological advancements continue to drive formulation development.

    Conclusions:

    • Perfluorocarbon emulsions necessitate individual assessment for clinical application.
    • Their complex mechanisms of action require further elucidation.
    • Widespread use as blood substitutes remains doubtful despite ongoing research.